Lyon, France, June 21, 2023 6:00 pm CET – MaaT Pharma (EURONEXT: MAAT – the “Company”), a clinical-stage biotechnology company and a leader in the development of Microbiome Ecosystem TherapiesTM (MET) dedicated to improving survival outcomes for patients with cancer, today announced new appointments to its Board and Executive team.
All resolutions presented during the annual general meeting were adopted in line with the Board recommendations.